James A. Robinson's most recent trade in UroGen Pharma Ltd was a trade of 10,000 Stock Option (right ot buy) done . Disclosure was reported to the exchange on June 22, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| UroGen Pharma Ltd | James A. Robinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2026 | 10,000 | 10,000 | - | - | Stock Option (right ot buy) | |
| UroGen Pharma Ltd | James A. Robinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2026 | 8,000 | 8,000 | - | - | Restricted Stock Unit | |
| UroGen Pharma Ltd | James A. Robinson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2026 | 2,000 | 6,000 (0%) | 0% | - | ordinary shares | |
| UroGen Pharma Ltd | James A. Robinson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2026 | 2,000 | 2,000 | - | - | Restricted Stock Unit | |
| UroGen Pharma Ltd | James A. Robinson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 2,000 | 2,000 (0%) | 0% | - | ordinary shares | |
| UroGen Pharma Ltd | James A. Robinson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 2,000 | 6,000 | - | - | Restricted Stock Unit | |
| UroGen Pharma Ltd | James A. Robinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 10,000 | 10,000 | - | - | Stock Option (right ot buy) | |
| UroGen Pharma Ltd | James A. Robinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 8,000 | 8,000 | - | - | Restricted Stock Unit | |
| UroGen Pharma Ltd | James A. Robinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2024 | 10,000 | 10,000 | - | - | Stock Option (right ot buy) | |
| UroGen Pharma Ltd | James A. Robinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Pacific Premier Bancorp Inc | James Allen Robinson | Sr.EVP, Head of Comm. Banking | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2023 | 37,707 | 101,727 (0%) | 0% | 0 | PPBI Common Stock | |
| Pacific Premier Bancorp Inc | James Allen Robinson | Sr.EVP, Head of Comm. Banking | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.02 per share. | 31 Mar 2023 | 692 | 64,020 (0%) | 0% | 24.0 | 16,622 | PPBI Common Stock |
| Pacific Premier Bancorp Inc | James Allen Robinson | Sr.EVP, Head of Comm. Banking | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 12,043 | 65,880 (0%) | 0% | 0 | PPBI Common Stock | |
| Pacific Premier Bancorp Inc | James Allen Robinson | Sr.EVP, Head of Comm. Banking | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.91 per share. | 15 Mar 2023 | 1,168 | 64,712 (0%) | 0% | 24.9 | 29,095 | PPBI Common Stock |
| Pacific Premier Bancorp Inc | James Allen Robinson | Sr.EVP, Head of Comm. Banking | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.35 per share. | 31 Mar 2022 | 992 | 53,837 (0%) | 0% | 35.3 | 35,067 | PPBI Common Stock |
| Pacific Premier Bancorp Inc | James Allen Robinson | Sr.EVP, Head of Comm. Banking | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 7,500 | 55,348 (0%) | 0% | 0 | PPBI Common Stock | |
| Pacific Premier Bancorp Inc | James Allen Robinson | Sr.EVP, Head of Comm. Banking | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.93 per share. | 15 Mar 2022 | 519 | 54,829 (0%) | 0% | 36.9 | 19,167 | PPBI Common Stock |
| Pacific Premier Bancorp Inc | James Allen Robinson | Sr.EVP, Head of Comm. Banking | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.71 per share. | 28 Feb 2022 | 5,297 | 47,848 (0%) | 0% | 38.7 | 205,047 | PPBI Common Stock |